Evidence map›Paper›PMID 41616709›Full record

ArticleComputers in biology and medicine2026

Influence of CT harmonization in longitudinal radiomics for NSCLC immunotherapy response prediction.

Benito Farina, Gonzalo Vegas-Sánchez-Ferrero, Ana Delia Ramos-Guerra, Carmelo Palacios Miras, Andrés Alcazar Peral, José Carmelo Albillos Merino, Jon Zugazagoitia, Germán R Peces-Barba, Luis Seijo Maceiras, Luis Paz-Ares and 4 more

Abstract read
In one paragraph

Article in Computers in biology and medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Benito FarinaBiomedical Image Technologies, ETSI Telecomunicación, Universidad Politécnica de Madrid, Madrid, 28040, Madrid, Spain; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Madrid, Spain. Electronic address: benito.farina@upm.es.
Gonzalo Vegas-Sánchez-FerreroACIL, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Ana Delia Ramos-GuerraBiomedical Image Technologies, ETSI Telecomunicación, Universidad Politécnica de Madrid, Madrid, 28040, Madrid, Spain; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Madrid, Spain.
Carmelo Palacios MirasClínica Universidad de Navarra, Madrid, 28027, Madrid, Spain.
Andrés Alcazar PeralClínica Universidad de Navarra, Madrid, 28027, Madrid, Spain.
José Carmelo Albillos MerinoHospital 12 de Octubre, Madrid, Madrid, Spain.
Jon ZugazagoitiaHospital 12 de Octubre, Madrid, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Madrid, Spain.
Germán R Peces-BarbaHospital Universitario Fundación Jiménez Díaz, Madrid, 28040, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Madrid, Spain.
Luis Seijo MaceirasClínica Universidad de Navarra, Madrid, 28027, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Madrid, Spain.
Luis Paz-AresHospital 12 de Octubre, Madrid, Madrid, Spain.
Ignacio Gil-BazoHospital 12 de Octubre, Madrid, Madrid, Spain; School of Medicine, Universidad Católica de Valencia (UCV), Valencia, Valencia, Spain.
Manuel Dómine GómezHospital Universitario Fundación Jiménez Díaz, Madrid, 28040, Madrid, Spain.
Raul San José EstéparACIL, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
María J Ledesma-CarbayoBiomedical Image Technologies, ETSI Telecomunicación, Universidad Politécnica de Madrid, Madrid, 28040, Madrid, Spain; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Madrid, Spain.

Funding

Prognostic Markers of Emphysema ProgressionR01HL149877 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SAN JOSE ESTEPAR, RAUL · 2020 to 2023
$2.8M
NHLBI NIH HHS R01 HL149877
6 · The paper itself

Abstract

This study investigates the variability of radiomic features in longitudinal CT scans from a multi-institutional NSCLC cohort and introduces a harmonization pipeline to improve predictive modeling of immunotherapy response. Baseline and follow-up CT scans from NSCLC patients treated with anti-PD-1/PD-L1 agents were analyzed, with two institutions combined for model training and internal testing, and a third institution serving as an external test set. To address variability from imaging parameters-such as scanner manufacturer, slice thickness, and noise-we applied image harmonization followed by feature harmonization using NestedComBat. This approach substantially reduced feature dependence on acquisition confounders (from 78.8% to 12.8%) and improved feature robustness across institutions. We further assessed the temporal consistency of radiomic features across longitudinal scans using the intraclass correlation coefficient (ICC). Image harmonization yielded the largest gains in stability (mean ΔICC = +0.021, p < 0.001), while the combined approach also enhanced longitudinal reliability (ΔICC = +0.014, p < 0.001). Finally, harmonization improved predictive performance for 6-month immunotherapy response, increasing the AUC from 0.695 to 0.768 in the internal test and from 0.692 to 0.802 in the external test. These results demonstrate that combining image- and feature-level harmonization enhances the robustness and temporal consistency of radiomic features, potentially supporting more reliable and generalizable predictive modeling across diverse datasets and clinical settings.

Indexed as

Carcinoma, Non-Small-Cell LungImmunotherapyLung NeoplasmsTomography, X-Ray ComputedAgedFemaleHumansLongitudinal StudiesMaleMiddle AgedRadiomicsComBatImage harmonizationImmunotherapyLongitudinal analysisLung cancerRadiomics

Identifiers

PMID41616709
PMCPMC13474272

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.